Glaxo goes head to head with UTC and both come out winners

Two A-rated corporates went head to head in the euro corporate bond market on Monday as UK pharmaceutical giant GlaxoSmithKline and US electrical systems manufacturer United Technologies Corp both launched triple-tranche deals, with two matching maturities, which totalled €4.5bn.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: